FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016507921> ?p ?o ?g. }

• W2016507921 endingPage "5312" @default.
• W2016507921 startingPage "5303" @default.
• W2016507921 abstract "The bioactivity of three methacryloyloxyethyl phosphate (MOEP) grafted expanded polytetrafluoroethylene (ePTFE) membranes with varying surface coverage as well as unmodified ePTFE was investigated through a series of in vitro tests: calcium phosphate (CaP) growth in simulated body fluid (SBF), serum protein adsorption, and a morphology and attachment study of human osteoblast-like SaOS-2 cells. The graft copolymers were prepared by means of gamma irradiation induced grafting and displayed various surface morphologies and wettabilities depending on the grafting conditions used. Unmodified ePTFE did not induce nucleation of CaP minerals, whereas all the grafted membranes revealed the growth of CaP minerals after 7 days immersion in SBF. The sample with lowest surface grafting yield (24% coverage), a smooth graft morphology and relatively high hydrophobicity (θadv=120°, θrec=80°) showed carbonated hydroxyapatite growth covering the surface. On the other hand, the samples with high surface grafting yield (76% and 100%), a globular graft morphology and hydrophilic surfaces (θadv=60° and 80°, θrec=25° and 15°, respectively) exhibited irregular growth of non-apatitic CaP minerals. Irreversibly adsorbed protein measured after a 1 h immersion in serum solution was quantified by the amount of nitrogen on the surface using XPS, as well as by weight increase. All grafted membranes adsorbed 3–6 times more protein than the unmodified membrane. The sample with the highest surface coverage adsorbed the most protein. Osteoblast-like SaOS-2 cells cultured for 3 h revealed significantly higher levels of cell attachment on all grafted membranes compared to unmodified ePTFE. Although the morphology of the cells was heterogeneous, in general, the higher grafted surfaces showed a much better cell morphology than both the low surface-grafted and the control unmodified sample. The suite of in vitro tests confirms that a judicious choice of grafted monomer such as the phosphate-containing methacrylate monomer (MOEP) significantly improves the bioactivity of ePTFE in vitro." @default.
• W2016507921 created "2016-06-24" @default.
• W2016507921 creator A5023155783 @default.
• W2016507921 creator A5031917154 @default.
• W2016507921 creator A5044914392 @default.
• W2016507921 creator A5082337082 @default.
• W2016507921 date "2005-09-01" @default.
• W2016507921 modified "2023-10-16" @default.
• W2016507921 title "In vitro bioactivity of MOEP grafted ePTFE membranes for craniofacial applications" @default.
• W2016507921 cites W1482733745 @default.
• W2016507921 cites W1541529924 @default.
• W2016507921 cites W1566307812 @default.
• W2016507921 cites W1985662025 @default.
• W2016507921 cites W1990221933 @default.
• W2016507921 cites W1991819046 @default.
• W2016507921 cites W1998117069 @default.
• W2016507921 cites W1999687686 @default.
• W2016507921 cites W2002049934 @default.
• W2016507921 cites W2006967073 @default.
• W2016507921 cites W2014451845 @default.
• W2016507921 cites W2017079868 @default.
• W2016507921 cites W2022702295 @default.
• W2016507921 cites W2028493164 @default.
• W2016507921 cites W2033602995 @default.
• W2016507921 cites W2037725221 @default.
• W2016507921 cites W2043197511 @default.
• W2016507921 cites W2057830569 @default.
• W2016507921 cites W2061351054 @default.
• W2016507921 cites W2067719770 @default.
• W2016507921 cites W2068660470 @default.
• W2016507921 cites W2069324624 @default.
• W2016507921 cites W2070416173 @default.
• W2016507921 cites W2077040528 @default.
• W2016507921 cites W2083483036 @default.
• W2016507921 cites W2085582576 @default.
• W2016507921 cites W2085688087 @default.
• W2016507921 cites W2089727953 @default.
• W2016507921 cites W2122996284 @default.
• W2016507921 cites W2142579416 @default.
• W2016507921 cites W2167417167 @default.
• W2016507921 doi "https://doi.org/10.1016/j.biomaterials.2005.01.061" @default.
• W2016507921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15814128" @default.
• W2016507921 hasPublicationYear "2005" @default.
• W2016507921 type Work @default.
• W2016507921 sameAs 2016507921 @default.
• W2016507921 citedByCount "52" @default.
• W2016507921 countsByYear W20165079212012 @default.
• W2016507921 countsByYear W20165079212013 @default.
• W2016507921 countsByYear W20165079212014 @default.
• W2016507921 countsByYear W20165079212015 @default.
• W2016507921 countsByYear W20165079212016 @default.
• W2016507921 countsByYear W20165079212017 @default.
• W2016507921 countsByYear W20165079212018 @default.
• W2016507921 countsByYear W20165079212019 @default.
• W2016507921 countsByYear W20165079212020 @default.
• W2016507921 countsByYear W20165079212021 @default.
• W2016507921 crossrefType "journal-article" @default.
• W2016507921 hasAuthorship W2016507921A5023155783 @default.
• W2016507921 hasAuthorship W2016507921A5031917154 @default.
• W2016507921 hasAuthorship W2016507921A5044914392 @default.
• W2016507921 hasAuthorship W2016507921A5082337082 @default.
• W2016507921 hasBestOaLocation W20165079212 @default.
• W2016507921 hasConcept C114874019 @default.
• W2016507921 hasConcept C115537861 @default.
• W2016507921 hasConcept C12554922 @default.
• W2016507921 hasConcept C127413603 @default.
• W2016507921 hasConcept C13965031 @default.
• W2016507921 hasConcept C150394285 @default.
• W2016507921 hasConcept C159985019 @default.
• W2016507921 hasConcept C171250308 @default.
• W2016507921 hasConcept C178790620 @default.
• W2016507921 hasConcept C185592680 @default.
• W2016507921 hasConcept C188027245 @default.
• W2016507921 hasConcept C192562407 @default.
• W2016507921 hasConcept C26771246 @default.
• W2016507921 hasConcept C2775937945 @default.
• W2016507921 hasConcept C2778414984 @default.
• W2016507921 hasConcept C41625074 @default.
• W2016507921 hasConcept C42360764 @default.
• W2016507921 hasConcept C499950583 @default.
• W2016507921 hasConcept C521977710 @default.
• W2016507921 hasConcept C54355233 @default.
• W2016507921 hasConcept C55493867 @default.
• W2016507921 hasConcept C61048295 @default.
• W2016507921 hasConcept C86803240 @default.
• W2016507921 hasConcept C88001094 @default.
• W2016507921 hasConceptScore W2016507921C114874019 @default.
• W2016507921 hasConceptScore W2016507921C115537861 @default.
• W2016507921 hasConceptScore W2016507921C12554922 @default.
• W2016507921 hasConceptScore W2016507921C127413603 @default.
• W2016507921 hasConceptScore W2016507921C13965031 @default.
• W2016507921 hasConceptScore W2016507921C150394285 @default.
• W2016507921 hasConceptScore W2016507921C159985019 @default.
• W2016507921 hasConceptScore W2016507921C171250308 @default.
• W2016507921 hasConceptScore W2016507921C178790620 @default.
• W2016507921 hasConceptScore W2016507921C185592680 @default.
• W2016507921 hasConceptScore W2016507921C188027245 @default.
• W2016507921 hasConceptScore W2016507921C192562407 @default.

• next